NCT07381777
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07381777 |
| Title | XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients (IMMUNOSTAR) |
| Acronym | IMMUNOSTAR |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Gruppo Oncologico Italiano di Ricerca Clinica |
| Indications | |
| Therapies | |
| Age Groups: | child | adult | senior |
| Covered Countries | ITA |
CKB BOOST